The patent trap? Open science advocates want CRISPR technology to be free

"The overall guiding principle is not open for the sake of 'open,' but whatever is necessary to find new treatments more rapidly for diseases." Dr. Guy Rouleau, director of the Montreal Neurological Institute at McGill University. 
Read more: CBC News